Ignacio Marcos-Campillo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The multiomics blueprint of the individual with the most extreme lifespan.
Journal: Cell reports. Medicine
Published: April 02, 2025
PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma.
Journal: Leukemia
Published: May 10, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study.
Journal: British journal of haematology
Published: December 21, 2023
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy.
Journal: Cancer research communications
Published: October 24, 2023
The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase.
Journal: Epigenetics & chromatin
Published: March 17, 2023
Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy.
Journal: Frontiers in cell and developmental biology
Published: May 26, 2021
Single-cell technologies and analyses in hematopoiesis and hematological malignancies.
Journal: Experimental hematology
Published: March 29, 2021
The human VRK1 chromatin kinase in cancer biology.
Journal: Cancer letters
Published: October 21, 2020
VRK1 Phosphorylates Tip60/KAT5 and Is Required for H4K16 Acetylation in Response to DNA Damage.
Journal: Cancers
Published: August 17, 2020
Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 14, 2019
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
Journal: Cellular and molecular life sciences : CMLS
Published: February 05, 2018
Last Updated: 09/26/2026